Marksans Pharma has informed that a meeting of the board of directors of the company will be held on December 14, 2012 to consider conversion of warrants and issue and allot in lieu thereof 1,75,00,000 equity shares of Rs. 1 each to Mark Saldanha, Promoter of the company on preferential allotment basis.
The above information is a part of company’s filings submitted to BSE.